Amp Capital Investors LTD Sarepta Therapeutics, Inc. Transaction History

Amp Capital Investors LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$69.38 - $86.75 $948,632 - $1.19 Million	-13,673 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$72.25 - $168.95 $21,675 - $50,685	300 Added 2.24%	13,673 $1.02 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $30,259 - $43,076	241 Added 1.84%	13,373 $2.29 Million
Q3 2020 Nov 12, 2020	SELL	$127.12 - $172.34 $1.01 Million - $1.37 Million	-7,964 Reduced 37.75%	13,132 $1.86 Million
Q2 2020 Aug 14, 2020	SELL	$93.0 - $171.7 $683,457 - $1.26 Million	-7,349 Reduced 25.84%	21,096 $3.43 Million
Q1 2020 May 13, 2020	SELL	$82.38 - $131.64 $73,647 - $117,686	-894 Reduced 3.05%	28,445 $2.8 Million
Q4 2019 Feb 13, 2020	BUY	$76.53 - $135.58 $1.01 Million - $1.78 Million	13,135 Added 81.06%	29,339 $3.78 Million
Q3 2019 Nov 13, 2019	BUY	$72.81 - $156.91 $1.18 Million - $2.54 Million	16,204 New	16,204 $1.22 Million

530

84.5M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

Stay updated on Amp Capital Investors LTD with notifications on news.